New Treatment for Multiple Sclerosis.
L Green - FDA Consumer, 2005 - questia.com
... The FDA has licensed a new approach to treat ... often disabling disease of the brain
and spinal ... The product, Tysabri (natalizumab), is given intravenously once a ...

[PDF] Natalizumab (Tysabri)
F known as Antegren - mstrust.org.uk
... 1. Introduction Tysabri is the first in a new class of ... In MS, it is believed that
immune cells pass through the blood-brain barrier into the central ...

US drug approval ignores science's subtleties, experts say -
E Waltz, N York - Nature Medicine, 2006 - nature.com
... New York. ... Tysabri launched in November 2004 after a fast-track approval from the ... Biogen
Idec, withdrew it after discovering that a rare brain infection called ...
-

SOCIETY NEWS -
B Pathology - Brain Pathology, 2007 - Blackwell Synergy
... who received Tysabri developed a rare brain infection not ... had developed in patients
who had received Tysabri. ... But even with these new clinical guidelines in ...
-

MAHLON DELONG: A HISTORICAL RATIONALE FOR DEEP BRAIN STIMULATION IN PARKINSON DISEASE, DYSTONIA, AND … -
A Goodman - Neurology Today, 2006 - neurotodayonline.com
... detailed how treatment with natalizumab (Tysabri) benefited patients ... He said the
FDA will review the new data on ... infection becomes active in the brain we have ...

Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis. -
KP Johnson - The Neurologist, 2007 - theneurologist.org
... Background: Natalizumab (Tysabri), a humanized monoclonal antibody which ... reducing
inflammation at the blood-brain barrier ... and reduced numbers of new lesions on ...

[PDF] Natalizumab (Tysabri) for Relapsing Multiple Sclerosis -
MOF ACTION - formkit.com
... 1 Natalizumab (Tysabri) is a recombi- nant humanized immunoglobulin ... of Caspi &
Associates in New York. ... osteopontin expressed by parenchymal cells in the brain. ...

What is an advance directive and who should have one?.
CP Sabatino - Neurology Now, 2005 - neurologynow.com
... those treated with the drug had no new lesions versus ... not known when - if ever -
natalizumab (Tysabri) will return ... The arrows on this brain scan point to the ...

Tysabri withdrawal calls entire class into question
N Immunology, D Discovery - Nature Medicine, 2005 - nature.com
... of the first to develop this new approach?to ... entering infected tissue outside the
brain, leaving patients ... The FDA in November 2004 granted Tysabri fast-track ...

[CITATION] FDA Approvals: Alvesco and Tysabri CME
L In, T Month, P Months